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Web Extra Table 1. Definitions 
Gastroenteritis/Diarrhoea Passage of stools of a less formed character than usual for that child occurring in 3 
or more episodes within 24 hours. 
Rotavirus confirmed case Vaccine age-eligible child presenting to QECH with diarrhoea and stool has 
positive rotavirus result on ELISA. 
Test-negative Vaccine age-eligible child presenting to QECH with diarrhoea and stool has 
negative rotavirus result on ELISA. 
Hospital admission Children staying overnight in hospital, or children requiring observation of >4 
hours in hospital short stay unit. 
Vaccine age-eligible Born on or after 17 September 2012 – age less than 6 weeks on date of vaccine 
introduction on 29 October 2012. 
HIV-exposed Any child born to an HIV-infected mother, or an infant <12 months old with a 
positive antibody test and absent HIV DNA PCR result or negative result in any 
infant still breastfeeding. 
HIV-infected Infant <12 months with positive HIV DNA PCR, or child 12 months or older with 
two sequential positive rapid antibody tests. 
Dehydration (for Vesikari score) None: Absence of any clinical sign of dehydration on admission. 
Mild-Moderate: Presence on admission of two or more of: 
 Restless or irritable 
 Sunken eyes 
 Thirsty or drinking eagerly 
 Slow skin pinch 
Severe: Presence on admission of two or more of: 
 Lethargic or unconscious 
 Sunken eyes 
 Drinks poorly or is unable to drink 
 Very slow skin pinch 
QECH = Queen Elizabeth Central Hospital 
ELISA = Enzyme-linked immunosorbent assay 
HIV DNA PCR = Human Immunodeficiency Virus deoxyribonucleic acid polymerase chain reaction 
 
Web Extra Table 2. Inclusion and exclusion criteria 
Inclusion criteria Case-patients were eligible for enrolment in the surveillance program if they met all of the following criteria: 
1. Are <5 years of age. 
2. Live in Blantyre district. 
3. Present to QECH with diarrhoea on or after the study start date 
4. Clinical illness should not be explained by an alternative underlying medical condition. 
5. Clinical illness commenced within 14 days prior to hospital visit; and 
6. Are either: 
a. Seen at QECH and treated with rehydration (oral or intravenous) for diarrhoea and discharged 
home; or 
b. Admitted to the hospital and treated for diarrhoea.  
7. Eligible to have received at least one dose of vaccine prior to illness (i.e. age 8 weeks or older and 
following date of vaccine introduction). 
8. Produce a rotavirus positive stool sample during the first 48 hours after presentation. 
Exclusion criteria Case-patients were excluded from enrolment in the active surveillance program if any of the following applied: 
1. Unable to contact parent or guardian to obtain informed consent. 
2. Admitted to another hospital for >24 hours (and subsequently transferred to QECH). 
3. Re-presentation within 14 days of previous hospital separation for the same illness. 
4. Hospital admission >48 hours prior to enrolment. 
5. Known oncological diagnosis or congenital immunodeficiency (apart from HIV infection). 
6. Enrolled prior to vaccine introduction. 
7. Age-ineligible to have received vaccine. 




Web Extra Table 3. Demographic and clinical characteristics of children younger than 5 
years presenting to Queen Elizabeth Central Hospital, Blantyre Malawi by case status, 
enrolled 1 January 2012 – 30 June 2014   
 Rotavirus Positive Rotavirus Negative  
 N=508 (%) N=933 (%) P-value 
Median age in months (range) 10•0 (0•5–41•9) 10•8 (0•4–58•9) <0•001a 
Median household size (range) 4 (2–12) 4 (2–15) 0•22a 
Median maternal age (range) 25 (15–54) 25 (16–42) 0•64a 
Maternal orphan 5 (1%) 16 (2%) 0•27 
Paternal orphan 5 (1%) 15 (2%) 0•34 
Preterm birth (<37 weeks) 13 (2.6%) 46 (5%) 0•81 
Median birth weight (kg) (range) 3 (1•5–5•5) 3 (1•1–5•0) 0•03 
HIV exposed 82 (17%) 175 (19%) 0•44 
HIV infected 20 (5%) 59 (8%) 0•05 
Currently breast fed 456 (91%) 729 (79%) <0•001* 
Exclusively breast fed 38 (8%) 45 (6%) 0•17 
Mean weight for age Z-score (SD) † -1•2 (1•3) -1•6 (1•6) <0•001 
Mean length for age Z-score (SD) -0•7 (2•6) -0•6(3•1) 0•66 
Diarrhoea 508 (100%) 933 (100%)  
Admitted inpatient 465 (92%) 844 (90%) 0•50 
Vesikari Score   <0•001b 
≤10 98 (19%) 317 (34%)  
10-14 301 (59%) 461 (47%)  
≥15 109 (21%) 153 (16%)  
Mean (SD) 12•0 (3•4) 11•2 (3•4) <0•001 
Verified Vaccination Status 459 (91%) 795 (85%) 0•006* 
a Wilcoxon Rank Sum test, b Mantel-Haenszel 2 test,  SD= Standard Deviation 
* Association lost once adjusted for age 



































Web Extra Figure 2. Age distribution of children <5years with rotavirus confirmed diarrhoea before 
vaccine introduction (1 January 2012 to 28 October 2012) and after vaccine introduction (29 October 





Web Extra Figure 3. Rotavirus genotypes among children <5 years of age presenting to Queen Elizabeth 
Central Hospital, Blantyre. Includes pre-rotavirus vaccine period (1 January 2012 to 28 October 2012) 
and post-rotavirus vaccine period (29 October 2012 to 30 June 2014). 
 
Web Extra Figure 4. Rotavirus hospitalization incidence and vaccination population coverage among 




Web Extra Figure 5. Age of rotavirus vaccination among recruited children presenting with diarrhoea to 
Queen Elizabeth Central Hospital, 1 January 2012 to 30 June 2014. DTP-HBV-HiB vaccine is shown for 
comparison. 
 
 
 
